Both in Biotechnology
Repligen vs ImmunityBio
Over the past year RGEN returned +19.0% and IBRX returned +273.9%; their daily moves had a correlation of 0.18.
RGEN +19.0% IBRX +273.9%Growth of $1, one year, split-adjusted
| Metric | RGEN | IBRX |
|---|---|---|
| Price | $178.72 | $8.45 |
| Market cap | $11.35B | $8.96B |
| Today | +0.25% | +1.93% |
| 1 month | +2.2% | −12.8% |
| 6 months | +42.1% | +0.8% |
| Year to date | +9.1% | +326.8% |
| 1 year | +19.0% | +273.9% |
| Revenue growth (YoY) | +10.9% | +93.9% |
| Gross margin | 53.0% | 99.4% |
| Net margin | −18.4% | −449.6% |
| P/E (TTM) | — | — |
| Price / sales | 14.1× | 54.0× |
| Net cash | $307.4M | -$57.7M |
| Dividend yield | — | — |
| Volatility (60d) | 47.3% | 68.5% |
| Short % of float | 12.8% | 31.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).